Evidence for a role of decitabine in the treatment of myeloid sarcoma.
Division of Hematology, Medical University of Graz, Graz, Austria.
Max
M
Gornicec
Division of Hematology, Medical University of Graz, Graz, Austria.
Albert
A
Wölfler
Department of Radiology, Division of Nuclear Medicine, Medical University of Graz, Graz, Austria.
Susanne
S
Stanzel
Division of Hematology, Medical University of Graz, Graz, Austria.
Heinz
H
Sill
Division of Hematology, Medical University of Graz, Graz, Austria. armin.zebisch@medunigraz.at.
Armin
A
Zebisch
D000368:Aged; D000369:Aged, 80 and over; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001374:Azacitidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077209:Decitabine; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D023981:Sarcoma, Myeloid / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine